Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT)
Dan Nakano(Kurume University), Takuji Torimura(Omuta hospital)
Cited by 84
Related Papers
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)
|Hepatology Research|2023|267
Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients
|Journal of Clinical Pathology|2017|81
Autoimmune hepatitis in Japan: trends in a nationwide survey
|Journal of Gastroenterology|2016|67
Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer
|Medical Molecular Morphology|2019|62